Home » Valeant to Buy PharmaSwiss for $480 Million
Valeant to Buy PharmaSwiss for $480 Million
Canada’s Valeant Pharmaceuticals International has agreed to buy PharmaSwiss, a Swiss-based privately held branded generic drugs firm, for 350 million euros ($480 million).
CNBC
CNBC
Upcoming Events
-
07May
-
14May
-
30May